Lynx1 Capital Management LP Q2 2025 Filing
Filed August 14, 2025
Portfolio Value
$346.2B
Holdings
15
Report Date
Q2 2025
Filing Type
13F-HR
All Holdings (15 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRUSMERUS N V | 1,568,841 | $82.5B | 23.84% | |
| 2 | GHRSGH RESEARCH PLC | 6,746,951 | $82.2B | 23.76% | |
| 3 | STOKSTOKE THERAPEUTICS INC | 5,404,674 | $61.3B | 17.72% | |
| 4 | PTGXPROTAGONIST THERAPEUTICS INC | 733,014 | $40.5B | 11.70% | |
| 5 | CGEMCULLINAN THERAPEUTICS INC | 4,400,842 | $33.1B | 9.57% | |
| 6 | ALLOALLOGENE THERAPEUTICS INC | 11,057,009 | $12.5B | 3.61% | |
| 7 | TCRXTSCAN THERAPEUTICS INC | 7,857,347 | $11.4B | 3.29% | |
| 8 | CCCCC4 THERAPEUTICS INC | 7,098,133 | $10.2B | 2.93% | |
| 9 | DTILPRECISION BIOSCIENCES INC | 1,036,051 | $4.4B | 1.26% | |
| 10 | PASGPASSAGE BIO INC | 9,256,953 | $3.7B | 1.07% | |
| 11 | UPBUPSTREAM BIO INC | 219,247 | $2.4B | 0.70% | |
| 12 | IBIOIBIO INC | 1,538,573 | $1.2B | 0.34% | |
| 13 | NEUPNEUPHORIA THERAPEUTICS INC | 45,806 | $325.2M | 0.09% | |
| 14 | DSGNDESIGN THERAPEUTICS INC | 65,954 | $222.3M | 0.06% | |
| 15 | ASMBASSEMBLY BIOSCIENCES INC | 10,366 | $187.8M | 0.05% |